Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/27/25 08:13 | 3/26/25 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 3 | P | 187 | 0.5630 | 0 | 332 | 11 | 3,341 | D | ||||||||||||||
3/27/25 08:13 | 3/26/25 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | 3 | P | 301 | 0.5932 | 0 | 507 | 19 | 3,243 | D | |||||||||||||||
12/10/24 16:01 | 12/9/24 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Still Timothy I | NV | D | 1 | P | 50 | 0.5722 | 0 | 87 | 6 | 1,487 | D | |||||||||||||||
12/10/24 16:01 | 12/9/24 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | 1 | P | 25 | 0.5722 | 0 | 44 | 10 | 487 | D | ||||||||||||||
12/19/23 10:59 | 12/18/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | 2 | P | 16 | 0.8000 | 0 | 20 | 8 | 278 | D | ||||||||||||||
12/14/23 09:11 | 12/13/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | 1 | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |